Top

Tag: Avidity


FDA, Regulations

FDA gives orphan drug status to Avidity’s rare muscular dystrophy treatment

February 15, 2023

Via: PMLiVE

The candidate will now benefit from the incentives given to those drugs granted orphan status through the FDA’s ODD programme, introduced by the organisation to improve the availability of treatments for rare diseases. FSHD is characterised by the life-long, progressive […]